期刊
CARDIOVASCULAR RESEARCH
卷 63, 期 3, 页码 500-509出版社
OXFORD UNIV PRESS
DOI: 10.1016/j.cardiores.2004.03.015
关键词
hypertrophy; signal transduction; negative regulation
资金
- NHLBI NIH HHS [HL69020, HL 59139, HL67724, HL67727] Funding Source: Medline
Throughout the past decade, much effort has been spent on deciphering the signaling pathways positively mediating cardiac hypertrophy. Recently, several endogenous molecules in the heart have been shown to negatively regulate cardiac hypertrophy. One group of these molecules is constitutively active at baseline, while molecules belonging to the second group serve as negative feedback regulators, which are activated in response to pathologic insults. Studies upon the negative regulators of cardiac hypertrophy may allow us to develop novel strategies to treat heart failure by mimicking the naturally preferred mechanisms to maintain homeostasis. In addition, the search for molecular targets of these negative regulators may allow us to identify novel positive mediators of hypertrophy. The aim of this article is to provide a brief overview of these newly identified negative regulators of cardiac hypertrophy. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据